Skip to content

Coloplast controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2019

    Transvaginal surgical mesh regulatory and litigation controversy

    Coloplast was among medical-device companies involved in litigation concerning transvaginal surgical mesh implants. In 2019, the U.S. FDA ordered Coloplast and Boston Scientific to stop selling and distributing certain mesh products for pelvic-organ-prolapse repair because the companies had not demonstrated that the products were safe and effective for that use. The episode followed earlier multimillion-dollar settlements and broader scrutiny of transvaginal mesh safety.